Fairlead Strategies Idea Generator
Jazz Pharmaceuticals (JAZZ) & Updates (K, VPU)
The Vanguard Utilities ETF (VPU) has reached our upside target, so we recommend taking profits. We also recommend taking profits in Kellogg (K) because it shows signs of upside exhaustion per the DeMARK Indicators®.
In a search for stocks with fresh technical catalysts, we found Jazz Pharmaceuticals (JAZZ) for our latest idea:
JAZZ pharmaceuticals has seen a long-term shift in momentum, noting the 200-day moving average has turned higher. The shift supports an extension higher toward the top of a multi-year trading range (~$189-190).
Short- and intermediate-term momentum have improved after holding long-term support at the 200-day moving average. Resistance has been reclaimed per the weekly cloud model (shaded area on the chart below), such that JAZZ appears poised to resume higher, helped by a stochastic “pop.”
An upside target can be gauged by long-term resistance and a measured move, both near $189. The most recent low near $149 can be used as a stop-loss level, likely to be revised higher.
Jazz Pharmaceuticals (JAZZ, $160.26)
Target: $189
Stop-Loss: $149
thank-you